Abo, H., Flannigan, K. L., Geem, D., Ngo, V. L., Harusato, A., & Denning, T. L. (2019). Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3(+) Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis. Front Immunol.
Chicago Style citaatAbo, Hirohito, Kyle L. Flannigan, Duke Geem, Vu L. Ngo, Akihito Harusato, en Timothy L. Denning. "Combined IL-2 Immunocomplex and Anti-IL-5 MAb Treatment Expands Foxp3(+) Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis." Front Immunol 2019.
MLA citatieAbo, Hirohito, et al. "Combined IL-2 Immunocomplex and Anti-IL-5 MAb Treatment Expands Foxp3(+) Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis." Front Immunol 2019.